Noveris Health Sciences Inc. MYCOF

Company Overview

Noveris Health Sciences Inc. is a publicly traded health sciences company associated with the development of biotechnology and wellness-related products, with historical activity tied to psychedelic medicine research, drug development, and health-focused consumer products. The company’s shares have traded on the OTC market under the ticker MYCOF, and public disclosures indicate that the business has undergone strategic and corporate transitions over time, including changes in branding and operational focus. Publicly available information suggests the company has explored opportunities in mental health therapeutics, pharmaceutical research, and related intellectual property development.

Available public filings and market disclosures indicate that the company has historically pursued commercialization opportunities connected to emerging health science sectors, particularly those involving novel therapeutic compounds and mental health treatment models. However, several operational and financial details are difficult to independently confirm through current public filings alone, and some historical disclosures appear tied to predecessor entities or prior corporate structures. Data inconclusive based on available public sources.